Minerva Neurosciences, Inc.
Minerva Neurosciences to Report First Quarter 2017 Financial Results and Business Updates on May 4, 2017
Management to host conference call
WALTHAM, Mass., April 27, 2017 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ:NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous system (CNS) disorders, today announced that it will release financial results and business updates for the first quarter of 2017 on Thursday, May 4, 2017. The Company will host a webcast and conference call that day at 8:30 a.m. Eastern Time to discuss these results and updates.
The live call may be accessed by dialing (877) 312-5845 for domestic callers or (765) 507-2618 for international callers and referring to conference ID number 2971783. A live webcast of the conference call will be available online in the Investors and Media section of the Company's website at ir.minervaneurosciences.com. The archived webcast will be available on the Company's website beginning approximately two hours after the event for 30 days.
About Minerva Neurosciences
Minerva Neurosciences, Inc. is a clinical-stage biopharmaceutical company focused on the development and commercialization of a portfolio of product candidates to treat CNS diseases. Minerva's proprietary compounds include: MIN-101, in clinical development for schizophrenia; MIN-117, in clinical development for major depressive disorder (MDD); MIN-202 (JNJ-42847922), in clinical development for insomnia and MDD; and MIN-301, in pre-clinical development for Parkinson's disease. Minerva's common stock is listed on the NASDAQ Global Market under the symbol "NERV." For more information, please visit www.minervaneurosciences.com .
William B. Boni
VP, Investor Relations/
Minerva Neurosciences, Inc.
Information om Globenewswire
Følg pressemeddelelser fra Globenewswire
Skriv dig op her, og modtag pressemeddelelser på e-mail. Indtast din e-mail, klik på abonner, og følg instruktionerne i den udsendte e-mail.
Flere pressemeddelelser fra Globenewswire
LeddarTech inc.18.12.2018 06:06 | Pressemeddelelse
LeddarTech Selects BlackBerry’s QNX Operating System for its Auto and Mobility LiDAR Platform
Align Technology, Inc.18.12.2018 02:31 | Pressemeddelelse
Align Technology Reaches 6 Millionth Invisalign® Patient Milestone With Tween Patient From China
ProQR Therapeutics N.V.17.12.2018 17:54 | Pressemeddelelse
ProQR Announces Publication in Nature Medicine of QR-110 Data for Leber’s Congenital Amaurosis 10
Allied Esports17.12.2018 15:31 | Pressemeddelelse
Allied Esports™ Announces Formation of World’s First Affiliate Program for Esports Venues
Biome Grow17.12.2018 14:55 | Pressemeddelelse
Biome Grow receives new consumer sales amendment from Health Canada for its Nova Scotia brand, Highland Grow
Bombardier Transportation17.12.2018 10:01 | Pressemeddelelse
Bombardier to supply a further 20 FLEXITY trams to Karlsruhe
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter samt finde vores kontaktoplysninger.Besøg vores nyhedsrum